FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809676434> ?p ?o ?g. }

• W2809676434 endingPage "1663" @default.
• W2809676434 startingPage "1655" @default.
• W2809676434 abstract "In Brief Purpose: To assess the ability of optical coherence tomography (OCT) alone and in combination with OCT angiography (OCTA) to differentiate polypoidal choroidal vasculopathy (PCV) from neovascular age-related macular degeneration, as compared to fluorescein angiography and indocyanine green angiography. Methods: This is a cross-sectional study. All participants had a standardized history, clinical examination including measurement of best-corrected visual acuity, slit-lamp biomicroscopy, and indirect fundus examination, and underwent standardized imaging (color photography, fluorescein and indocyanine green angiography, OCT, and OCTA) after predefined protocols. We used a 2-step approach (Step 1: spectral domain OCT; Step 2: addition of OCTA) combining structural OCT and OCTA to differentiate 50 treatment-naive eyes with PCV, choroidal neovascularization, and retinal angiomatous proliferation and compared with the diagnosis based on fluorescein angiography and indocyanine green angiography. Spectral domain OCT signs used to diagnose PCV included presence of two out of three of any retinal pigment epithelium detachment (pigment epithelial detachment/double-layer sign), notched or narrow-peaked pigment epithelial detachment, or round subretinal pigment epithelium structure. Optical coherence tomography angiography signs used to diagnose PCV included presence of a localized subretinal pigment epithelium hyperflow signal in the cross-sectional OCTA and/or presence of a focal hyperflow sign in en face OCTA based on outer retina slab. Results: Based on fluorescein angiography and indocyanine green angiography, the diagnosis was choroidal neovascularization in 24 eyes, PCV in 23 eyes, and retinal angiomatous proliferation in 3 eyes. Based on spectral domain OCT signs, PCV was diagnosed in 19/23 (82.6%) eyes; however, specificity of OCT was only 51.9%. Cross-sectional OCTA showed a diffuse hyperflow signal in all 24 (100.0%) eyes with choroidal neovascularization, whereas a localized subretinal pigment epithelium hyperflow signal was detected in 19/23 (82.6%) eyes with PCV. En face OCTA only detected a nodular hyperflow signal in 10/23 eyes (43.5%) with PCV. Combination of OCT and OCTA achieved 82.6% sensitivity and 100.0% specificity for differentiating PCV from choroidal neovascularization/retinal angiomatous proliferation. Conclusion: Cross-sectional OCTA is more sensitive than en face OCTA in detecting flow signal in polyps. Combination of structural OCT and OCTA can be used to screen for PCV with a high level of sensitivity and specificity. We compared cross-sectional and structural optical coherence tomography angiography in differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration and found that combination of structural optical coherence tomography and optical coherence tomography angiography provides improved accuracy in differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration." @default.
• W2809676434 created "2018-06-29" @default.
• W2809676434 creator A5012380371 @default.
• W2809676434 creator A5022402846 @default.
• W2809676434 creator A5031473097 @default.
• W2809676434 creator A5067399804 @default.
• W2809676434 creator A5072258594 @default.
• W2809676434 creator A5078487748 @default.
• W2809676434 creator A5080762568 @default.
• W2809676434 creator A5081776983 @default.
• W2809676434 date "2019-09-01" @default.
• W2809676434 modified "2023-09-30" @default.
• W2809676434 title "IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY" @default.
• W2809676434 cites W1806345065 @default.
• W2809676434 cites W1821433096 @default.
• W2809676434 cites W1966232476 @default.
• W2809676434 cites W1976433015 @default.
• W2809676434 cites W1986076674 @default.
• W2809676434 cites W1992253461 @default.
• W2809676434 cites W2011653842 @default.
• W2809676434 cites W2033011949 @default.
• W2809676434 cites W2053888627 @default.
• W2809676434 cites W2062809532 @default.
• W2809676434 cites W2094687424 @default.
• W2809676434 cites W2207811656 @default.
• W2809676434 cites W2215271879 @default.
• W2809676434 cites W2272470265 @default.
• W2809676434 cites W2290063535 @default.
• W2809676434 cites W2318417808 @default.
• W2809676434 cites W2319897080 @default.
• W2809676434 cites W2322602077 @default.
• W2809676434 cites W2338221729 @default.
• W2809676434 cites W2466513253 @default.
• W2809676434 cites W2492736086 @default.
• W2809676434 cites W2548980142 @default.
• W2809676434 cites W2553904803 @default.
• W2809676434 cites W2559448980 @default.
• W2809676434 cites W2587055868 @default.
• W2809676434 cites W2588612709 @default.
• W2809676434 cites W2753466306 @default.
• W2809676434 cites W2766739581 @default.
• W2809676434 cites W2767248066 @default.
• W2809676434 cites W2769653767 @default.
• W2809676434 cites W4242385022 @default.
• W2809676434 cites W4251857773 @default.
• W2809676434 doi "https://doi.org/10.1097/iae.0000000000002228" @default.
• W2809676434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29927796" @default.
• W2809676434 hasPublicationYear "2019" @default.
• W2809676434 type Work @default.
• W2809676434 sameAs 2809676434 @default.
• W2809676434 citedByCount "36" @default.
• W2809676434 countsByYear W28096764342019 @default.
• W2809676434 countsByYear W28096764342020 @default.
• W2809676434 countsByYear W28096764342021 @default.
• W2809676434 countsByYear W28096764342022 @default.
• W2809676434 countsByYear W28096764342023 @default.
• W2809676434 crossrefType "journal-article" @default.
• W2809676434 hasAuthorship W2809676434A5012380371 @default.
• W2809676434 hasAuthorship W2809676434A5022402846 @default.
• W2809676434 hasAuthorship W2809676434A5031473097 @default.
• W2809676434 hasAuthorship W2809676434A5067399804 @default.
• W2809676434 hasAuthorship W2809676434A5072258594 @default.
• W2809676434 hasAuthorship W2809676434A5078487748 @default.
• W2809676434 hasAuthorship W2809676434A5080762568 @default.
• W2809676434 hasAuthorship W2809676434A5081776983 @default.
• W2809676434 hasConcept C118487528 @default.
• W2809676434 hasConcept C126838900 @default.
• W2809676434 hasConcept C142724271 @default.
• W2809676434 hasConcept C2776391266 @default.
• W2809676434 hasConcept C2776403814 @default.
• W2809676434 hasConcept C2776474195 @default.
• W2809676434 hasConcept C2778024200 @default.
• W2809676434 hasConcept C2778818243 @default.
• W2809676434 hasConcept C2780248432 @default.
• W2809676434 hasConcept C2780643987 @default.
• W2809676434 hasConcept C2780827179 @default.
• W2809676434 hasConcept C2781065829 @default.
• W2809676434 hasConcept C2781359195 @default.
• W2809676434 hasConcept C2910234007 @default.
• W2809676434 hasConcept C71924100 @default.
• W2809676434 hasConceptScore W2809676434C118487528 @default.
• W2809676434 hasConceptScore W2809676434C126838900 @default.
• W2809676434 hasConceptScore W2809676434C142724271 @default.
• W2809676434 hasConceptScore W2809676434C2776391266 @default.
• W2809676434 hasConceptScore W2809676434C2776403814 @default.
• W2809676434 hasConceptScore W2809676434C2776474195 @default.
• W2809676434 hasConceptScore W2809676434C2778024200 @default.
• W2809676434 hasConceptScore W2809676434C2778818243 @default.
• W2809676434 hasConceptScore W2809676434C2780248432 @default.
• W2809676434 hasConceptScore W2809676434C2780643987 @default.
• W2809676434 hasConceptScore W2809676434C2780827179 @default.
• W2809676434 hasConceptScore W2809676434C2781065829 @default.
• W2809676434 hasConceptScore W2809676434C2781359195 @default.
• W2809676434 hasConceptScore W2809676434C2910234007 @default.
• W2809676434 hasConceptScore W2809676434C71924100 @default.
• W2809676434 hasIssue "9" @default.
• W2809676434 hasLocation W28096764341 @default.
• W2809676434 hasLocation W28096764342 @default.

• next